Key facts
- This page summarizes Jeffrey D. Alter's Form 4 filing for Anthem, Inc. (ELV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Oct 2021, 16:30.
Jeffrey D. Alter - 01 Oct 2021 Form 4 Insider Report for Anthem, Inc. (ELV)
- Reporting relationship
- EVP, IngenioRx & Anthem Health
- Issuer ticker
- ELV
- Reported as of
- 01 Oct 2021
- Net transaction value
- -$116,914
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2021, 16:30:49 UTC
- Prior SEC filing
- 16 Jun 2021
- Next SEC filing
- 17 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey D. Alter filed Form 4 for Anthem, Inc. (ELV) on 04 Oct 2021.
Change
- Previous filing in this sequence was filed on 16 Jun 2021.
- Current net transaction value: -$116,914.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Tax liability
- Transaction value
- $116,914
- Shares
- -311
- Change %
- -5.7%
- Price
- $375.93
- Shares after
- 5,107
- Date
- 01 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2
Includes 22.60 shares acquired under the Anthem, Inc. Employee Stock Purchase Plan, in transactions exempt under Rule 16b-3.